A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol - Hajda, Jacek; Lehmann, Monika; Kieser, Meinhard; Jäger, Dirk; Schöning, Tilman; Sedlaczek, Oliver; Stenzinger, Albrecht; Halama, Niels; Daniel, Volker; Engeland, Christine Elisabeth; Springfeld, Christoph (BioMed Central; Springer, 2017)
Aus: BMC Cancer, 17 (2017), Nr. 576. pp. 1-11. ISSN 1471-2407